- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Diagnostic Equipment
Snapshot for Cepheid Inc (CPHD)
| Open: | 38.8000 | Day's Range: | 38.0400 - 39.4900 | Volume: | 330,622 |
|---|---|---|---|---|---|
| Previous Close: | 38.2600 | 52wk Range: | 28.1200 - 46.0000 | 1-Yr Rtn: | +1.54% |
Key Statistics for CPHD
| Current P/E Ratio (ttm) | 1,275.3333 |
|---|---|
| Estimated P/E(12/2013) | 95.1741 |
| Relative P/E vs. SPX | 78.9297 |
| Earnings Per Share (USD) (ttm) | 0.0300 |
| Est. EPS (USD) (12/2013) | 0.4020 |
| Est. PEG Ratio | 5.8150 |
| Market Cap (M USD) | 2,567.49 |
| Shares Outstanding (M) | 67.11 |
| 30 Day Average Volume | 450,283 |
| Price/Book (mrq) | 9.8140 |
| Price/Sale (ttm) | 7.3319 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/19/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CPHD
Company Profile & Key Executives for CPHD
Cepheid, Inc. is a molecular diagnostics company dedicated to improving healthcare with its molecular systems and tests. The Company enables institutions to access the full power of molecular diagnostics with genetic testing for organisms and genetic-based diseases.
| John L BishopChairman/CEO | Andrew D MillerExec VP/CFO |
| Humberto ReyesExec VP/COO | David H PersingExec VP/Chief Medical Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CPHD News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page